Rare diseases
Investigational molecules
Locations
Back to Croatia24 clinical trials in Varazdin, Croatia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
CroatiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
CroatiaStudy on Ublituximab for Patients with Relapsing Multiple Sclerosis
CroatiaA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
CroatiaStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
CroatiaStudy comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis
CroatiaStudy on Fenebrutinib for Patients with Relapsing Multiple Sclerosis
CroatiaStudy on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
CroatiaStudy on Lowering Cholesterol with Rosuvastatin or Rosuvastatin/Ezetimibe in Patients at High or Very High Risk of Cardiovascular Disease with High Cholesterol
CroatiaStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
CroatiaStudy on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
CroatiaStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Multiple Sclerosis treatments, including studies of novel therapies and comparative effectiveness of existing medications. Multiple trials are evaluating treatments for both relapsing-remitting and primary progressive forms of MS.
Several innovative compounds being tested include fenebrutinib, ocrelizumab, and ublituximab for enhanced disease management.
Comprehensive studies addressing various cardiovascular conditions, from heart failure to prevention of major cardiovascular events. Research includes innovative treatments for atrial fibrillation and stroke prevention.
Trials evaluating new compounds like milvexian and finerenone for improved cardiovascular outcomes.
Clinical research examining new treatments for moderate to severe asthma, with a focus on improving control in patients with persistent symptoms. Studies evaluating novel therapeutic approaches for better disease management.
Investigation of new compounds like atuliflapon for enhanced asthma control.
Innovative research in breast cancer treatment, particularly focusing on hormone-receptor-positive cases. Studies evaluating targeted therapies for early-stage breast cancer.
Clinical trials examining giredestrant as a potential new treatment option.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
